Skip to main content
. 2022 Aug 25;24(12):2283–2296. doi: 10.1111/dom.14829

TABLE 1.

Epidemiological studies of cardio‐renal‐metabolic disease in Japan

Authors (year of publication) Type of study Number of subjects Findings
T2D and CVD
Shiba et al. (2011) 8 Prospective, multicentre, cohort study 10 219 22.5% of HF patients had diabetes
Cui et al. (2011) 26 Prospective, multicentre, cohort study 35 657 Diabetes associated with increased risk of stroke:
  • Men: HR 1.64 (95% CI: 1.21‐2.23)

  • Women: HR 2.19 (95% CI: 1.53‐3.12)

Akao et al. (2013) 27 Cross‐sectional, multicentre, cohort study 3183 23.2% of patients with atrial fibrillation had diabetes
Sato et al. (2013) 28 Prospective, multicentre, cohort study 4842 33.8% of hospitalized HF patients had diabetes
Kato et al. (2015) 29 Prospective, multicentre, cohort study 99 584 Diabetes associated with increased risk of death from IHD:
  • Men: HR 2.32 (95% CI: 1.78‐3.03)

  • Women: HR 4.56 (95% CI: 3.17‐6.57)

Takabayashi et al. (2016) 30 Prospective, multicentre, cohort study 647 31.8% of hospitalized HF patients had diabetes
Hirakawa et al. (2017) 25 Pooled analysis of 8 cohort studies 38 854 Diabetes associated with an increased risk of death from:
  • CV death: HR 1.62 (95% CI: 1.35‐1.94)

  • CHD: HR 2.13 (95% CI: 1.47‐3.09)

  • Stroke: HR 1.40 (95% CI: 1.05‐1.85)

Yaku et al. (2018) 31 Prospective, multicentre, cohort study 4056 37% of hospitalized HF patients had diabetes (HFrEF 40%; HFpEF 33%)
Kaku et al. (2020) 32 Retrospective, multicentre, cohort study 198 861 26.2% of hospitalized HF patients had diabetes
Sato et al. (2020) 33 Prospective, multicentre, cohort study 4876 39.5% of elderly HF patients had diabetes
Ide et al. (2021) 34 Retrospective, multicentre, cohort study 13 238 34.2% of hospitalized HF patients had diabetes
Kaneko et al. (2021) 35 Cross‐sectional database study 1 180 062 In individuals aged 20 to 49 years, diabetes was associated with an increased risk for:
  • Myocardial infarction: HR 2.09 (95% CI: 1.61‐2.71)

  • Angina: HR 1.59 (95% CI: 1.42‐1.78)

  • Stroke: HR 1.31 (95% CI: 1.07‐1.59)

  • HF: HR 1.58 (95% CI: 1.41‐1.78)

  • Atrial fibrillation: HR 1.69 (95% CI: 1.35‐2.13)

Seo et al. (2021) 36 Prospective, single‐centre, cohort study 349 43% of hospitalized HF patients had diabetes (HFrEF 42%; HFpEF 41%)
Ohsugi et al. (2021) 37 Cross‐sectional database study 10 151 2.8% of T2D patients had myocardial infarction, while 7.6% had ischaemic stroke
T2D and CKD
Ohta et al. (2010) 38 Retrospective, single‐centre, cohort study 3575 46.0% of T2D patients had CKD
Iwai et al. (2018) 39 Prospective, multicentre, cohort study 2484 28.1% of CKD patients had diabetes
Yokoyama et al. (2018) 40 Cross‐sectional, multicentre, cohort study 7251 Prevalence of CKD in T2D patients declined from 32.6% to 22.3% from 2004 to 2014
Nitta et al. (2019) 41 Cross‐sectional, multicentre, cohort study 1088 41.7% of CKD patients had diabetes
Yoshida et al. (2020) 42 Cross‐sectional, multicentre, cohort study 2385 54.0% of T2D patients had CKD
CKD and CVD
Tanaka et al. (2017) 43 Prospective, multicentre, cohort study 2966 8.6 HF events per 1000 person‐years in CKD patients
Kon et al. (2018) 44 Cross‐sectional, multicentre, cohort study 132 160 HR 2.28 (95% CI: 1.28‐4.03) for CV death in elderly patients with eGFR < 45 ml/min/1.73m2 compared with those with eGFR > 90 ml/min/1.73m2
Yaku et al. (2018) 31 Prospective, multicentre, cohort study 4056 45% of HF patients had CKD
Nitta et al. (2019) 41 Cross‐sectional, multicentre, cohort study 1088 23.4% of CKD patients had left ventricular hypertrophy
Sato et al. (2020) 33 Prospective, multicentre, cohort study 4876 47.7% of elderly HF patients had CKD
Ide et al. (2021) 34 Retrospective, multicentre, cohort study 13 238 38.9% of HF patients had CKD

Abbreviations: CHD, coronary heart disease; CI, confidence interval; CKD, chronic kidney disease; CV, cardiovascular; CVD, cardiovascular disease; eGFR, estimated glomerular filtration rate; HF, heart failure; HFpEF, heart failure with preserved ejection fraction; HFrEF, heart failure with reduced ejection fraction; HR, hazard ratio; IHD, ischaemic heart disease; T2D, type 2 diabetes.